tiprankstipranks
Trending News
More News >
Yomeishu Seizo Co., Ltd. (JP:2540)
:2540
Japanese Market
Advertisement

Yomeishu Seizo Co., Ltd. (2540) AI Stock Analysis

Compare
0 Followers

Top Page

JP:2540

Yomeishu Seizo Co., Ltd.

(2540)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 4o)
Rating:68Neutral
Price Target:
Yomeishu Seizo Co., Ltd. demonstrates solid financial stability, with strong equity and no debt. However, declining profitability and the absence of free cash flow raise concerns about operational efficiency and growth prospects. The high P/E ratio implies potential overvaluation, although the stock's positive technical momentum suggests current market optimism.

Yomeishu Seizo Co., Ltd. (2540) vs. iShares MSCI Japan ETF (EWJ)

Yomeishu Seizo Co., Ltd. Business Overview & Revenue Model

Company DescriptionYomeishu Seizo Co., Ltd. produces and sells herbal liqueurs and pharmaceutical products in Japan, Hong Kong, Malaysia, Singapore, and Taiwan. It offers Yomeishu, an herbal liqueur; ginger, ginseng, honey, and medicinal liqueur; fruit and herbs liqueur; Kanomori and Kanoshizuku gin; and craft gin cocktail products. The company also provides Yomeishu cough drops; Yomeishu Seizo Amazake; Herb-no-Megumi; Ururu vinegar drinks; ginger black vinegar drinks; and dilution type black vinegar drinks. In addition, it offers Koken Seisai designated quasi-pharmaceutical and health products through the mail order site www.yomeishu-online.jp. Further, the company operates CLASUWA, a commercial complex; rents/leases real estate properties; manages restaurants and shops; and generates, supplies, and sells electricity through natural energy. Yomeishu Seizo Co., Ltd. was incorporated in 1923 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyYomeishu Seizo Co., Ltd. generates revenue primarily through the sale of its health-focused beverages, with the Yomeishu tonic being its flagship product. The company markets its products through various retail channels, including supermarkets, pharmacies, and online platforms, both domestically and internationally. Additionally, Yomeishu Seizo may engage in strategic partnerships and collaborations with other companies to expand its market reach and product offerings. The company's earnings are significantly influenced by consumer demand for health and wellness products, as well as its ability to innovate and introduce new products that meet consumer preferences.

Yomeishu Seizo Co., Ltd. Financial Statement Overview

Summary
Yomeishu Seizo Co., Ltd. showcases strong financial stability with a debt-free balance sheet and a high equity ratio. However, the declining revenue and net profit margins over recent periods indicate challenges in maintaining profitability and growth. The absence of free cash flow further points to potential operational concerns.
Income Statement
75
Positive
The company's gross profit margin is strong at 58.3% (TTM), indicating efficient cost management. However, the net profit margin has decreased from 9.3% to 7.6% (TTM), suggesting a decline in profitability. Revenue has decreased over the years, with a decline from JPY 10.64 billion (2023) to JPY 9.98 billion (TTM), reflecting a challenging growth environment.
Balance Sheet
85
Very Positive
The company has a robust equity position with a debt-to-equity ratio of 0, reflecting no reliance on debt financing. The equity ratio is high at 85.3% (TTM), indicating strong financial stability. ROE has slightly decreased from 2.39% (2023) to 1.62% (TTM), suggesting some weakness in generating returns on equity.
Cash Flow
60
Neutral
The cash flow statement indicates a lack of free cash flow generation, with a negative free cash flow in the latest annual report. Both operating and free cash flow ratios are unavailable due to zero net income (TTM), highlighting potential operational inefficiencies.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue9.99B10.02B10.24B10.65B10.58B10.38B
Gross Profit5.63B5.42B6.14B6.60B6.68B6.39B
EBITDA2.14B1.70B1.97B2.01B1.97B1.68B
Net Income784.26M679.58M952.82M1.02B949.90M807.56M
Balance Sheet
Total Assets52.55B53.52B54.42B49.56B48.61B47.87B
Cash, Cash Equivalents and Short-Term Investments5.05B5.71B8.15B8.93B5.89B9.14B
Total Debt0.000.000.000.000.000.00
Total Liabilities6.92B7.46B7.77B6.77B6.43B6.31B
Stockholders Equity45.63B46.06B46.64B42.79B42.18B41.56B
Cash Flow
Free Cash Flow0.00-2.67B-1.92B1.36B1.29B752.61M
Operating Cash Flow0.00473.12M667.52M1.75B1.81B1.41B
Investing Cash Flow0.00-1.19B2.31B-1.45B-1.40B-217.20M
Financing Cash Flow0.00-623.03M-760.15M-554.77M-551.81M-551.50M

Yomeishu Seizo Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price4020.00
Price Trends
50DMA
3886.30
Positive
100DMA
3508.02
Positive
200DMA
3097.10
Positive
Market Momentum
MACD
39.40
Positive
RSI
62.27
Neutral
STOCH
56.30
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2540, the sentiment is Positive. The current price of 4020 is above the 20-day moving average (MA) of 3973.75, above the 50-day MA of 3886.30, and above the 200-day MA of 3097.10, indicating a bullish trend. The MACD of 39.40 indicates Positive momentum. The RSI at 62.27 is Neutral, neither overbought nor oversold. The STOCH value of 56.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2540.

Yomeishu Seizo Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
¥69.42B15.262.03%3.24%
73
Outperform
¥30.70B10.422.23%1.16%-23.94%
68
Neutral
¥55.44B70.971.12%-1.83%-6.10%
67
Neutral
¥42.22B14.830.78%10.79%27.11%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
62
Neutral
¥23.50B69.651.66%-3.66%-77.47%
60
Neutral
¥30.26B12.261.87%0.57%12.46%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:2540
Yomeishu Seizo Co., Ltd.
4,020.00
1,611.64
66.92%
JP:2266
Rokko Butter Co., Ltd.
1,206.00
-293.22
-19.56%
JP:2831
Hagoromo Foods Corporation
3,215.00
82.41
2.63%
JP:2874
YOKOREI CO. LTD.
1,180.00
236.14
25.02%
JP:2915
KENKO Mayonnaise Co., Ltd.
1,886.00
-390.32
-17.15%
JP:2923
Sato Foods Co., Ltd.
8,370.00
403.09
5.06%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 08, 2025